[1]刘芸 段华**.GnRHa治疗对中、重度宫腔粘连手术结局的影响[J].中国微创外科杂志,2014,14(6):522-525.
　Liu Yun,Duan Hua. Corresponding author:Duan Hua,E mail:duanhua888@.com.Effects of GnRHagonist on Patients Receiving Resection of Moderatetosevere Intrauterine Adhesion[J].Chinese Journal of Minimally Invasive Surgery,2014,14(6):522-525.
点击复制

GnRHa治疗对中、重度宫腔粘连手术结局的影响()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
14
期数:
2014年6期
页码:
522-525
栏目:
出版日期:
2014-06-20

文章信息/Info

Title:
Effects of GnRHagonist on Patients Receiving Resection of Moderatetosevere Intrauterine Adhesion
作者:
刘芸 段华**
首都医科大学附属北京妇产医院妇科微创中心，北京100006
Author(s):
Liu Yun;  Duan Hua. Corresponding author:Duan Hua; Email:duanhua888@163.com
Minimally Invasive Center of Gynecolgy, Beijing Gynecology & Obstetrics Hospital Affiliated to Capital Medical University, Beijing 100006, China
关键词:
宫腔粘连; 子宫内膜异位症; 促性腺激素释放激素激动剂; 宫内节育器; 雌激素
Keywords:
Intrauterine adhension; Endometriosis; Gonadotropin releasing hormone agonist; Interuterine device(IUD); Estrogens
分类号:
R711.71
文献标志码:
A
摘要:
目的探讨促性腺激素释放激素激动剂（GnRHa）对宫腔镜下宫腔粘连分离术（transcevical resection of adhesions,TCRA）后结局的影响。方法选取2008年1月~2013年6月我院妇科微创中心由同一医生施行TCRA的27例中、重宫腔粘连（中度19例，重度8例）合并Ⅲ~Ⅳ期子宫内膜异位症作为研究组，TCRA术后放置宫内节育器（IUD），GnRHa治疗3个周期；同期接受TCRA术后人工周期药物治疗3个周期，但未进行GnRHa治疗的94例宫腔粘连（中度66例,重度28例）作为对照组。TCRA术后3个月宫腔镜检查评估术后效果，同时检测研究组GnRHa治疗3个月后雌二醇（E2）水平和对照组人工周期3个月后月经第2天E2水平。结果研究组术后1个月内3例（11.1%）盆腔炎症，对照组5例（53%），2组比较差异无统计学意义（χ2=0.395，P=0530)，8例经抗炎治疗2周后治愈。TCRA术后3个月宫腔镜检查：研究组治疗有效率77.8%（中度16例，重度5例），对照组治疗有效率75.5%（中度52例，重度19例），2组比较无统计学差异（Z=-0095，P=0.924)。研究组GnRHa 3个月后E2为（19.12±8.53）pg/ml，对照组E2为（163.72±77.69）pg/ml，2组比较有统计学差异（t=-9.626，P=0000)。结论GnRHa造成的低雌激素状态不影响TCRA的术后效果。
Abstract:
ObjectiveTo explore the effects of GnRHagonist on patients receiving transcervical resection of adhesions (TCRA).MethodsA total of 27 cases of intrauterine adhensions (moderate, 19 cases; severe, 8 cases) combined with stage Ⅲ or Ⅳ endometriosis, receiving TCRA by the same doctor, from January 2008 to June 2013 in this hospital was enrolled as the study group. After the TCRA, an interuterine device (IUD) was put in and 3 cycles of GnRHagonist medication were given. Another group of 94 cases of intrauterine adhensions (moderate, 66 cases; severe, 28 cases) during the same period, which received TCRA and artificial cycle therapy but no GnRHagonist medication, was selected as the control group. All the patients received 3 months followup and had the second hysteroscopy to evaluate the uterine shape and the serum E2 at the second day of the fourth cycle.ResultsThe total effective rate was 77.8% in the study group (moderate, 16 cases; severe, 5 cases) and 75.5% in the control group (moderate, 52 cases; severe, 19 cases). There was no significant difference between the two groups (Z=-0.095, P=0.924). The serum E2 was significant lower in the study group as compared with the control group ［(19.12±8.53) pg/ml vs. (163.72±77.69) pg/ml, t=-9626, P=0.000］. Three cases in the study group (11.1%) and 5 cases in the control group (5.3%) received antibiotic medication for pelvic inflammation,and there was no statistical difference between the two groups(χ2=0.395,P=0.530).ConclusionLow level of E2 induced by GnRHagonist does not influence the result of the TCRA, but the abnormal uterine bleeding when using GnRHagonist may increase the risk of pelvic inflammation after TCRA.

参考文献/References:

[1]Amer MI, AhdEIMaeboud KH. Amnion graft following hysteroscopic lysis of intrauterine adhesions．J Obstet Gynaecol Res,2006,32(6):559-566.
[2]Elchalal U, Schenker JG. Pre and postoperative hormonal treatment in patients with hysteroscopic surgery. Contrib Gynecol Obstet, 2000,20:1-12.
[3]冯缵冲,邵敬於,主编.实用宫腔镜学.上海:上海医科大学出版社,1999.68-72.
[4]Deans R, Abbott J. Review of intrauterine adhesions．J Minim lnvasive Gynecol,2010,17:555-569．
[5]Yu D, Wong YM, Cheong Y, et a1．Asherman syndrome-one century later. Fertil Steril，2008,89:759-779．
[6]Rmer T, Schmidt T, Foth D. Hysteroscopic resection of uterus septus versus abdominal metroplasty. J Am Coll Surg,1994,178(6):637-644.
[7]Tonguc EA, Var T, Yilmaz N, et al. Intrauterine device or estrogen treatment after hysteroscopic uterine septum resection. Int J Gynaecol Obstet,2010,109(3):226-229.
[8]胡珈瑞，陈兴会，Ghosh D.人体子宫内膜血管内皮生长因子的研究.武汉大学学报（医学版），2001，22（2）：145-147.
[9]韩义娜,任琛琛,申爱荣,等.VEGF在宫腔粘连患者子宫内膜中的表达及与IL18、TNFα的关系. 中国妇幼保健,2011, 26(29):4494-4496.
[10]陈芳,段华,张颖,等.不同水平雌激素在宫腔粘连形成中的作用及相关机制.中华妇产科杂志2010,45(12):917-920.
[11]刘大菊,田秦杰,陈蓉,等.促性腺激素释放激素激动剂预防子宫纵隔切除术后宫腔粘连的初步研究.生殖医学杂志, 2013,22(2):83-86.

备注/Memo

备注/Memo:
*基金项目：国家临床重点专科建设项目（妇科）；北京市医院管理局临床医学发展专项（项目编号:ZY201406）；生殖与生育重大疾病诊治的规范化与推广（项目编号：201002013）**通讯作者，Email: duanhua888@163.com
更新日期/Last Update: 2014-12-08